Press Releases 

Helomics® Corporation Announces the appointment of Dr. Marc Malandro to its Advisory Board, providin

PITTSBURGH–January 4, 2018- Helomics® Corporation (Helomics), a privately-held, healthcare company providing personalized medicine solutions for clients in the pharmaceutical, diagnostic, and biotech industries, today announced the addition of Marc Malandro PhD, CLP, RTTP, currently Vice President of Operations for Science at the Chan Zuckerberg Initiative, to its Advisory Board. The addition of Dr. Malandro provides significant scientific and business expertise to Helomics as well as Helomics’ recently announced joint venture with Skyline Medical Inc (NASDAQ: SKLN) to build-out and commercialize the Helomics D-CHIP™ platform Marc Malandro, PhD, CLP, RTTP was the founding director of the Inn

Archive
 Follow Us
  • LinkedIn Social Icon
  • Facebook Basic Square
  • Twitter Basic Square

© 2020 Helomics Corp. All rights reserved.

  • White Twitter Icon
  • Facebook - White Circle
  • White LinkedIn Icon